Pinkpepper Hemp Cultivar and Primer Set for High-CBD Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current South Korean laws classify all Cannabis sativa L. products as narcotics, limiting the development and use of medical hemp cultivars with high CBD content, despite international recognition of its therapeutic benefits, and traditional domestic hemp cultivars have low CBD levels unsuitable for medical and industrial purposes.
Innovation Solution
Development of a new Cannabis sativa L. cultivar named Pinkpepper, achieved through artificial crossing of KHV2 and India genetic resources, with high CBDA and CBD content, suitable for smart farm cultivation, allowing two harvests per year, and resistant to flowering daylight length, along with a primer set for identification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional domestic hemp cultivars are used, then cultivation is straightforward, but CBD content is low and unsuitable for medical purposes
Solution Approach 1:
The patent applies parameter changes by developing a new hemp cultivar with fundamentally different chemical composition parameters. The Pinkpepper cultivar achieves CBDA content exceeding 10% and CBD content exceeding 5%, representing a dramatic shift from the low CBD levels of traditional domestic cultivars. This parameter transformation enables the hemp to transition from unsuitable to highly suitable for medical and industrial applications.
2Quantity of substance
If hemp cultivars with high CBD content are developed, then medical utility is improved, but legal classification as narcotic may worsen due to THC content
Solution Approach 1:
The patent utilizes parameter changes to fundamentally alter the cannabinoid profile of the hemp cultivar. The Pinkpepper cultivar is engineered to maintain extremely low THC content while achieving exceptionally high CBDA and CBD content. This parameter transformation allows the hemp to produce therapeutic cannabinoids without triggering narcotic classification, thereby resolving the legal barrier to medical hemp development in South Korea.
3Productivity
If autoflowering cultivar is developed, then productivity increases with two harvests per year, but resistance to daylight length conditions must be maintained
Solution Approach 1:
The patent applies parameter changes by introducing autoflowering genetics that fundamentally alter the flowering response parameters of the hemp cultivar. The Pinkpepper cultivar exhibits autonomous flowering capability, allowing it to transition from vegetative to reproductive stage based on age rather than photoperiod. This parameter transformation enables two harvests per year while maintaining reliable resistance to daylight length variations, achieving both high productivity and environmental stability.
Data Source
AI summary
A hempseed oil or a seed protein is derived from a feminized seed. The feminized seed is obtained by induction of a male flower on a female plant of a hemp cultivar Pinkpepper (Cannabis sativa L. cv. Pinkpepper) plant. The hemp cultivar Pinkpepper plant is obtained through artificial crossing between KHV2 genetic resource as a seed parent and Inida genetic resource as a pollen parent, the hemp cultivar Pinkpepper plant having a higher content of cannabinoids than the seed and pollen parents, the hemp cultivar Pinkpepper plant deposited under Accession Number KACC 88008BP.